GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex first isolated from human plasma in the 1970s by biochemist Loren Pickart. With search interest surging over 1,000% year-over-year, it has become one of the most actively researched peptides in regenerative science. Here's what makes it so compelling.
GHK-Cu is a tripeptide (three amino acids: glycine, histidine, lysine) that naturally binds copper(II) ions with high affinity. It is found in human plasma, saliva, and urine, with concentrations declining significantly with age - from approximately 200 ng/mL in plasma at age 20 to roughly 80 ng/mL by age 60.
This age-related decline, combined with the peptide's broad biological activity, has made it a central subject in aging and regenerative research.
Molecular profile: GHK-Cu has a molecular weight of 403.9 Da, making it one of the smallest bioactive peptides studied. Its compact size allows efficient tissue penetration and cellular uptake.
Unlike most peptides that act through a single receptor pathway, GHK-Cu exerts its effects primarily through gene expression modulation. A landmark 2012 study by Pickart et al. using the Broad Institute's Connectivity Map (cMap) database identified that GHK-Cu influences the expression of 4,382 genes - roughly 6% of the human genome.
GHK-Cu's most established research area is wound healing. Studies dating back to the 1980s demonstrated accelerated wound closure, increased angiogenesis, and enhanced granulation tissue formation in animal models. The peptide appears to coordinate the wound healing cascade - attracting immune cells, promoting fibroblast proliferation, stimulating collagen deposition, and eventually supporting remodelling.
Multiple controlled studies have shown GHK-Cu increases skin thickness, reduces fine lines, improves elasticity, and enhances overall skin density when applied topically. A notable study by Leyden et al. found that GHK-Cu cream applied for 12 weeks produced measurable increases in collagen synthesis compared to controls. For a longer-form field note on the dermal-density evidence (cutometer studies, biopsy work, and one striking n=1 tactile observation), see our companion piece on GHK-Cu and skin thickness. For the wider collagen-and-skin literature across peptides, see peptides for skin and collagen.
GHK-Cu has been shown to enlarge hair follicle size and stimulate hair growth in animal models. It appears to extend the anagen (growth) phase of the hair cycle while increasing follicular blood supply through VEGF stimulation. For the broader hair-growth peptide landscape (including GHK-Cu’s role alongside other follicle-active compounds), see our guide to peptides for hair growth.
Emerging research explores GHK-Cu's potential neuroprotective effects. Its ability to upregulate nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) genes, combined with its anti-inflammatory and antioxidant properties, has generated interest in neurodegeneration research.
A 2010 study in Genome Medicine analyzed gene expression data from COPD patients and found that GHK-Cu could theoretically reverse many of the pathological gene expression patterns associated with emphysematous lung destruction. This remains an active area of investigation.
Several factors explain GHK-Cu's explosive growth in research attention - and why it consistently appears in our annual roundup of the most-researched peptides of 2026 alongside BPC-157 and the GLP-1 family:
GHK-Cu is typically studied via:
The reconstituted solution should be stored at 2-8°C and used within 30 days. See our reconstitution guide for preparation instructions, and review the storage guide for temperature and light-exposure best practices. Use the reconstitution calculator to confirm volumes before drawing. Always verify batch purity by reading the COA.
GHK-Cu is the compound behind much of the “copper peptide” and “anti-aging injection” coverage that went mainstream in 2025–2026. Plastic-surgery and dermatology commentators have amplified it: in a widely shared LinkedIn post, Dr. Ethan Baughman, MD PhD FACS, summarised the topical skin literature, reporting that GHK-Cu has repeatedly improved skin firmness, elasticity and thickness in controlled trials and - citing the International Journal of Medical Science - that it accelerates wound closure and supports tissue remodelling. We report this as third-party commentary; the named clinician is not affiliated with New-U.
This is also why GHK-Cu surfaces next to questions like “why is Japanese skin so flawless?” - traditions such as rice-bran (nuka) skincare keep skin-matrix and barrier biology in the cultural conversation, and GHK-Cu sits in that same matrix-and-collagen research space. The overlap is topical-skin science, not a New-U cosmetic claim: our materials remain research use only, not for human consumption.
What is GHK-Cu?
GHK-Cu is a naturally occurring tripeptide (glycine-histidine-lysine) bound to copper(II) ions. Found in human plasma, saliva, and urine, its concentrations decline with age. Research shows it influences over 4,000 genes.
Why is GHK-Cu research interest growing?
Search interest has surged over 1,000% YoY due to genomic data showing it affects 4,382 genes, convergence with ageing research, a well-documented safety profile, and versatility across dermatology, wound healing, and neuroscience.
How is GHK-Cu administered in research?
Typically via subcutaneous injection (1–4 mg daily), topical application (1–2% solution), or iontophoresis. The reconstituted solution should be stored at 2–8°C.
Is GHK-Cu worth the hype?
The research case carries it: an endogenous tripeptide that declines with age, modulates 4,000+ genes, and has shown skin-firmness, elasticity and wound-healing effects in controlled work (as highlighted in commentary from clinicians such as Dr. Ethan Baughman). Still a research compound - no human-use or cosmetic claims.
How long is GHK-Cu used in research cycles?
Research and consumer literature commonly describe short, defined windows with reassessment between them rather than continuous indefinite use. Descriptive research context only - not a dosing protocol or human-use instruction.
New-U Research Compounds stocks GHK-Cu in 10-vial packs, independently verified by Janoshik and Freedom Diagnostics.
View GHK-Cu